BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 27637635)

  • 1. Reconsideration of Hemodynamic Cerebral Ischemia Using Recent PET/SPECT Studies.
    Nakagawara J
    Acta Neurochir Suppl; 2016; 123():99-108. PubMed ID: 27637635
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Accuracy of brain perfusion single-photon emission computed tomography for detecting misery perfusion in adult patients with symptomatic ischemic moyamoya disease.
    Setta K; Kojima D; Shimada Y; Yoshida J; Oshida S; Fujimoto K; Tsutsui S; Chiba T; Fujiwara S; Terasaki K; Ogasawara K
    Ann Nucl Med; 2018 Nov; 32(9):611-619. PubMed ID: 30030783
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of the addition of
    Ogasawara K; Takahashi T; Igarashi S; Yabuki M; Omori D; Akamatsu Y; Chida K; Kobayashi M; Fujiwara S; Terasaki K
    Ann Nucl Med; 2023 May; 37(5):280-288. PubMed ID: 36805493
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Detection of misery perfusion with split-dose 123I-iodoamphetamine single-photon emission computed tomography in patients with carotid occlusive diseases.
    Imaizumi M; Kitagawa K; Hashikawa K; Oku N; Teratani T; Takasawa M; Yoshikawa T; Rishu P; Ohtsuki T; Hori M; Matsumoto M; Nishimura T
    Stroke; 2002 Sep; 33(9):2217-23. PubMed ID: 12215590
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Two-Year Clinical, Cerebral Hemodynamic, and Cognitive Outcomes of Adult Patients Undergoing Medication Alone for Symptomatically Ischemic Moyamoya Disease Without Cerebral Misery Perfusion: A Prospective Cohort Study.
    Miyoshi K; Chida K; Kobayashi M; Kubo Y; Yoshida K; Terasaki K; Ogasawara K
    Neurosurgery; 2019 Jun; 84(6):1233-1241. PubMed ID: 29850833
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cerebral hemodynamics and metabolism in adult moyamoya disease: comparison of angiographic collateral circulation.
    Piao R; Oku N; Kitagawa K; Imaizumi M; Matsushita K; Yoshikawa T; Takasawa M; Osaki Y; Kimura Y; Kajimoto K; Hori M; Hatazawa J
    Ann Nucl Med; 2004 Apr; 18(2):115-21. PubMed ID: 15195758
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of Effects between Clopidogrel and Cilostazol on Cerebral Perfusion in Nonsurgical Adult Patients with Symptomatically Ischemic Moyamoya Disease: Subanalysis of a Prospective Cohort.
    Chiba T; Setta K; Shimada Y; Yoshida J; Fujimoto K; Tsutsui S; Yoshida K; Kobayashi M; Kubo Y; Fujiwara S; Terasaki K; Ogasawara K
    J Stroke Cerebrovasc Dis; 2018 Nov; 27(11):3373-3379. PubMed ID: 30174225
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hemodynamic improvement of anterior cerebral artery territory perfusion induced by bifrontal encephalo(periosteal) synangiosis in pediatric patients with moyamoya disease: a study with brain perfusion SPECT.
    Song YS; Oh SW; Kim YK; Kim SK; Wang KC; Lee DS
    Ann Nucl Med; 2012 Jan; 26(1):47-57. PubMed ID: 22033781
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hemodynamic reserve and high-intensity transient signals in moyamoya disease.
    Horn P; Lanczik O; Vajkoczy P; Daffertshofer M; Bueltmann E; Werner A; Schmiedek P; Hennerici M
    Cerebrovasc Dis; 2005; 19(3):141-6. PubMed ID: 15644625
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cerebral blood flow and oxygen metabolism measurements using positron emission tomography on the first day after carotid artery stenting.
    Kawai N; Hatakeyama T; Okauchi M; Kawanishi M; Shindo A; Kudomi N; Yamamoto Y; Nishiyama Y; Tamiya T
    J Stroke Cerebrovasc Dis; 2014 Feb; 23(2):e55-64. PubMed ID: 24119366
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Role of PET and SPECT in the assessment of ischemic cerebrovascular disease.
    Heiss WD; Podreka I
    Cerebrovasc Brain Metab Rev; 1993; 5(4):235-63. PubMed ID: 8110593
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Feasibility of 62Cu-ATSM PET for evaluation of brain ischaemia and misery perfusion in patients with cerebrovascular disease.
    Isozaki M; Kiyono Y; Arai Y; Kudo T; Mori T; Maruyama R; Kikuta K; Okazawa H
    Eur J Nucl Med Mol Imaging; 2011 Jun; 38(6):1075-82. PubMed ID: 21287169
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Quantitative evaluation of cerebral hemodynamics in patients with moyamoya disease by dynamic susceptibility contrast magnetic resonance imaging--comparison with positron emission tomography.
    Tanaka Y; Nariai T; Nagaoka T; Akimoto H; Ishiwata K; Ishii K; Matsushima Y; Ohno K
    J Cereb Blood Flow Metab; 2006 Feb; 26(2):291-300. PubMed ID: 16049427
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Unique Angiographic Appearances of Moyamoya Disease Detected with 3-Dimensional Rotational Digital Subtraction Angiography Imaging Showing the Hemodynamic Status.
    Karakama J; Nariai T; Hara S; Hayashi S; Sumita K; Inaji M; Tanaka Y; Wagatsuma K; Ishii K; Nemoto S; Maehara T
    J Stroke Cerebrovasc Dis; 2018 Aug; 27(8):2147-2157. PubMed ID: 29653803
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Vascular reserve in chronic cerebral ischemia measured by the acetazolamide challenge test: comparison with positron emission tomography.
    Nariai T; Suzuki R; Hirakawa K; Maehara T; Ishii K; Senda M
    AJNR Am J Neuroradiol; 1995 Mar; 16(3):563-70. PubMed ID: 7793382
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of pre-surgery assessments on the prognosis of patients received extracranial-intracranial bypass surgery.
    Li C; Cao X; Ma Z; Sun X; Hu F; Wang L
    Restor Neurol Neurosci; 2018; 36(5):593-604. PubMed ID: 30010157
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hemodynamic stress distribution identified by SPECT reflects ischemic symptoms of Moyamoya disease patients.
    Arai N; Horiguchi T; Takahashi S; Nakahara T; Akiyama T; Jinzaki M; Yoshida K
    Neurosurg Rev; 2020 Oct; 43(5):1323-1329. PubMed ID: 31444715
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Diagnosis of hemodynamic compromise in patients with chronic cerebral ischemia; measurement of cerebral blood volume (CBV) with 99mTc-RBC SPECT].
    Kuroda S; Takigawa S; Kamiyama H; Abe H; Sakuragi M; Motomiya M; Nakagawa T; Mitsumori K; Tsuru M
    No Shinkei Geka; 1990 Mar; 18(3):259-66. PubMed ID: 2359476
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Unraveling Specific Brain Microstructural Damage in Moyamoya Disease Using Diffusion Magnetic Resonance Imaging and Positron Emission Tomography.
    Hara S; Hori M; Ueda R; Hayashi S; Inaji M; Tanaka Y; Maehara T; Ishii K; Aoki S; Nariai T
    J Stroke Cerebrovasc Dis; 2019 Apr; 28(4):1113-1125. PubMed ID: 30679013
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Time-course analysis of brain perfusion single photon emission computed tomography using a three-dimensional stereotactic region-of-interest template in patients with moyamoya disease.
    Marushima A; Tsurushima H; Suzuki K; Nakai Y; Nemoto H; Matsumura A
    World Neurosurg; 2011; 76(3-4):304-10. PubMed ID: 21986429
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.